ClinConnect ClinConnect Logo
Search / Trial NCT04981184

Informative of Surface Electromyography and Prognostic Factors in Assessing the Recovery of Balance and Gait After Stroke

Launched by LITHUANIAN UNIVERSITY OF HEALTH SCIENCES · Jul 27, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Surface Electromyography Gait Balance Ischemic Stroke

ClinConnect Summary

This clinical trial is looking into how a special test called surface electromyography (EMG) can help us understand how well people recover their balance and walking after having a stroke. The researchers want to find out what factors might predict a patient’s chance of improving in these areas during their rehabilitation, which is the second stage of recovery after a stroke.

To participate, individuals must be between 18 and 89 years old and have had their first stroke, known as a cerebral infarction. They should be able to walk on their own and have some muscle strength. Participants will need to provide their consent to join the study. If chosen, they can expect to undergo assessments that will help both their recovery process and contribute to our understanding of stroke rehabilitation. This trial is currently recruiting participants, and it's an opportunity to help advance knowledge in stroke recovery while receiving support for their own rehabilitation journey.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Cerebral infarction for the first time;
  • Age from 18 to 89 years old;
  • Muscle strength according to the Oxford scale is 3-5 points;
  • Able to walk without the help of others;
  • Is able to communicate and understand instructions properly;
  • Agrees to participate in the study (voluntary, explicit, informed written consent to participate).
  • Exclusion Criteria:
  • Muscle strength according to the Oxford scale is 0-2 points;
  • Unable to walk without the help of others;
  • Sensorimotor aphasia or other perceptual disorders;
  • Do not sign the informed consent.

About Lithuanian University Of Health Sciences

The Lithuanian University of Health Sciences (LSMU) is a leading academic institution dedicated to advancing health sciences through innovative research and education. With a strong emphasis on interdisciplinary collaboration, LSMU conducts clinical trials aimed at improving patient outcomes and enhancing healthcare practices. The university's commitment to rigorous scientific inquiry is complemented by its state-of-the-art facilities and a network of experienced professionals, making it a pivotal player in the field of medical research in Lithuania and beyond. Through its clinical trials, LSMU strives to contribute valuable insights to the global medical community while fostering the next generation of healthcare leaders.

Locations

Kaunas, , Lithuania

Patients applied

0 patients applied

Trial Officials

Eglė Lendraitienė, PhD

Principal Investigator

LUHS

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials